B.Well Swiss AG launched a PRO-115 nebulizer with a shape similar to and includes three masks, one each for babies, kids, and adults. Further, the nebulizer provides prompt relief from coughs and bronchitis in both children and adults and is considered an ideal nebulizer for the entire family since it makes inhalation enjoyable.
PARI Pharma GmbH announced the approval for the LAMIRA Nebulizer System the first registered drug-specific eFlow Technology nebulizer to provide patients in Japan a new course of treatment.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3915
Published Date: Nov 30, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing incidence of respiratory diseases among children and the growing advancements in respiratory care devices are the major factors driving the growth of the market.
The market size of pediatric nebulizer mask is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.
The major players in the market are OMRON Corporation, VYAIRE MEDICAL, INC, GF Health Products Inc., Rossmax International Ltd., DeVilbiss Healthcare LLC., and others.
The pneumatic nebulizer segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.